Optimizing remission rates using antithyroid drugs for Graves' disease.
Hegedüs
Laszlo
L
Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark. laszlo.hegedus@ouh.regionsyddanmark.dk
D013956:Antithyroid Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002138:Calibration; D003131:Combined Modality Therapy; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006111:Graves Disease / Q000188:drug therapy* / Q000453:epidemiology / Q000601:surgery; D006801:Humans; D011193:Potassium Iodide / Q000008:administration & dosage; D015995:Prevalence; D012074:Remission Induction; D016896:Treatment Outcome
D013956:Antithyroid Agents; D011193:Potassium Iodide